Donovan Michael Patrick

Track

Insider profile

Performance

Overall performance
3.5
Performance over holding periods
3.5
30 days 90 days 120 days
Average return 10% 8.2% 15.1%
Success rate 97% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Donovan Michael Patrick's trades of AxoGen, Inc.'s stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
381.79
Quantity 23,308
Value US$2,996,795
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
136.19
Quantity 71,603 +20.4%
Value US$4,977,287
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
73.58
Quantity 86,998 +34.6%
Value US$1,968,458
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
7.68
Quantity 716 -1.8%
Value US$5,499
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
8.81
Quantity 36,310 -50.4%
Value US$319,891
US AxoGen, Inc. (AXGN)
Transaction date
Proposed sale
Price
8.81
Quantity 36,310
Value US$319,779
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
20.04
Quantity 1,935 -4.5%
Value US$38,777
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
19.15
Quantity 1,808 -4.2%
Value US$34,623
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
17.81
Quantity 567 -2.0%
Value US$10,098
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
17.19
Quantity 279 -1.1%
Value US$4,796
US AxoGen, Inc. (AXGN)
Transaction date
Sale
Price
16.42
Quantity 96 -0.4%
Value US$1,576
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
15.00
Quantity 17,617 -40.4%
Value US$264,255
US AxoGen, Inc. (AXGN)
Transaction date
Planned sale
Price
20.00
Quantity 20,000 -51.3%
Value US$400,000
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-08-21 2024-08-21
US AxoGen, Inc. (AXGN)
PrS Proposed sale
23,308
381.79
US$2,996,795 		23,308 381.79 US$2,996,795
2024-03-25 2024-03-21
US AxoGen, Inc. (AXGN)
S Sale
71,603 +20.4%
136.19
US$4,977,287 		71,603 +20.4% 136.19 US$4,977,287
2024-03-25 2024-03-21
US AxoGen, Inc. (AXGN)
S Sale
86,998 +34.6%
73.58
US$1,968,458 		86,998 +34.6% 73.58 US$1,968,458
2024-03-25 2024-03-21
US AxoGen, Inc. (AXGN)
S Sale
716 -1.8%
7.68
US$5,499 		716 -1.8% 7.68 US$5,499
2024-03-08 2024-03-07
US AxoGen, Inc. (AXGN)
S Sale
36,310 -50.4%
8.81
US$319,891 		36,310 -50.4% 8.81 US$319,891
2024-03-07 2024-03-07
US AxoGen, Inc. (AXGN)
PrS Proposed sale
36,310
8.81
US$319,779 		36,310 8.81 US$319,779
2021-07-23 2021-07-21
US AxoGen, Inc. (AXGN)
PlS Planned sale
1,935 -4.5%
20.04
US$38,777 		1,935 -4.5% 20.04 US$38,777
2021-02-19 2021-02-18
US AxoGen, Inc. (AXGN)
PlS Planned sale
1,808 -4.2%
19.15
US$34,623 		1,808 -4.2% 19.15 US$34,623
2020-12-30 2020-12-29
US AxoGen, Inc. (AXGN)
S Sale
567 -2.0%
17.81
US$10,098 		567 -2.0% 17.81 US$10,098
2020-12-23 2020-12-22
US AxoGen, Inc. (AXGN)
PlS Planned sale
279 -1.1%
17.19
US$4,796 		279 -1.1% 17.19 US$4,796
2020-12-22 2020-12-21
US AxoGen, Inc. (AXGN)
S Sale
96 -0.4%
16.42
US$1,576 		96 -0.4% 16.42 US$1,576
2020-11-12 2020-11-09
US AxoGen, Inc. (AXGN)
PlS Planned sale
17,617 -40.4%
15.00
US$264,255 		17,617 -40.4% 15.00 US$264,255
2019-06-14 2019-06-13
US AxoGen, Inc. (AXGN)
PlS Planned sale
20,000 -51.3%
20.00
US$400,000 		20,000 -51.3% 20.00 US$400,000